S. Yokota

M. Ohta, N. Sawabata, H. Maeda, 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Prognostic predictors for survival in patients with COPD using cardiopulmonary exercise testing

S. Yokota, A. Hirotani, Y. Okuda, 2003, Clinical physiology and functional imaging.

Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case-control study.

H. Kato, M. Tsuboi, S. Kudoh, 2008, American journal of respiratory and critical care medicine.

Phase I-II study of amrubicin and cisplatin in previously untreated patients with extensive-stage small-cell lung cancer.

N. Saijo, Y. Nishiwaki, Y. Ohe, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Association of cigarette smoking with the expression of nuclear survivin in pathological Stage IA lung adenocarcinomas

H. Maeda, S. Yokota, M. Mori, 2014, Medical Molecular Morphology.

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104.

N. Saijo, Y. Nishiwaki, M. Fukuoka, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancer.

K. Mori, N. Saijo, Y. Ichinose, 2012, Lung cancer.

A Phase II Study Directed by a Clinical Pathway for Carboplatin and Weekly Paclitaxel in Previously Untreated Patients with Unresectable Non-Small Cell Lung Cancer

I. Kawase, K. Matsui, F. Imamura, 2010, Chemotherapy.

Phase II study of erlotinib in Japanese patients with advanced non-small cell lung cancer.

M. Tsuboi, K. Mori, K. Eguchi, 2010, Anticancer research.

Phase III randomized trial of docetaxel plus cisplatin versus vindesine plus cisplatin in patients with stage IV non-small-cell lung cancer: the Japanese Taxotere Lung Cancer Study Group.

M. Shibuya, Y. Ichinose, Y. Nishiwaki, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy of anti-PD-1/PD-L1 antibodies after discontinuation due to adverse events in non-small cell lung cancer patients (HANSHIN 0316)

S. Negoro, N. Katakami, S. Yokota, 2018, BMC Cancer.

Case series of pleomorphic carcinomas of the lung treated with nivolumab

S. Yokota, M. Mori, Y. Yano, 2017, Thoracic cancer.

Nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung (WJOG5208L): a randomised, open-label, phase 3 trial.

T. Yamanaka, H. Saka, K. Goto, 2015, The Lancet. Oncology.

[Characteristics and management of patients with lung cancer and idiopathic interstitial pneumonia].

S. Yokota, M. Mori, T. Ogura, 1996, Nihon Kyobu Shikkan Gakkai zasshi.

Gefitinib in patients with brain metastases from non-small-cell lung cancer: review of 15 clinical cases.

T. Kijima, H. Maeda, S. Yokota, 2004, Clinical lung cancer.

TREATMENT PERIODS AND SUBJECTS IN THE COHORT AND NUMBER OF CASES AND CONTROLS IN THE NESTED CASE-CONTROL

H. Kato, M. Tsuboi, S. Kudoh, 2008 .

Phase II trial of pemetrexed continuation--maintenance after carboplatin-based induction in untreated non-squamous non-small cell lung cancer.

I. Kawase, T. Kijima, F. Imamura, 2013, Anticancer research.

Simultaneous bilateral spontaneous pneumothorax observed during the administration of gefitinib for lung adenocarcinoma with multiple lung metastases.

S. Yokota, Y. Namba, M. Mori, 2005, Internal medicine.

Synergistic Potentiation of in VivoAntitumor Activity of Anti-Human T-Leukemia Immunotoxins by Recombinant Â «-Interferonand Daunorubicin 1

Yi Luo, S. Yokota, H. Hara, 2006 .

Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients—Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study

Young Hak Kim, K. Eguchi, Y. Ohashi, 2016, Supportive Care in Cancer.

Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin-induced hepatotoxicity.

Y. Yamamoto, J. Azuma, T. Fukuda, 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Involvement of interleukin-6 in the elevation of plasma fibrinogen levels in lung cancer patients.

S. Yokota, T. Ogura, Y. Yamamoto, 1998, Japanese journal of clinical oncology.

A randomized double-blind phase IIa dose-finding study of ZD6474 in Japanese patients with NSCLC.

M. Tsuboi, K. Eguchi, M. Fukuoka, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Augmentative effect ofNocardia rubra cell-wall skeleton on the induction of human lymphokine-activated killer (LAK) cells by the production of LAK cell helper factor(s)

I. Kawase, T. Shirasaka, S. Yokota, 2005, Cancer Immunology, Immunotherapy.

Effect of IL-6 elevation in malignant pleural effusion on hyperfibrinogenemia in lung cancer patients.

S. Yokota, T. Ogura, H. Kimura, 2000, Japanese journal of clinical oncology.

55 Phase II study of amrubicin (SM-5887), a novel 9-amino-anthracycline, in previously untreated patients with extensive-stage small-cell lung cancer (ES-SCLC): A trial of the west Japan lung cancer group

M. Fukuoka, S. Negoro, S. Yokota, 1997 .

Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.

I. Kawase, T. Inoue, T. Shirasaka, 1988, Cancer research.

Minimal influence of tocilizumab on IFN-c synthesis by tuberculosis antigens Atsushi OgataMasahide MoriShoji HashimotoYukihiro YanoTakeya FujikawaMari Kawai • Yusuke KuwaharaToru HiranoJunsuke ArimitsuKeisuke HagiharaYoshihito Shima • Masashi NarazakiSouichirou YokotaTadamitsu KishimotoIchiro Kawase

M. Kawai, T. Hirano, Y. Kuwahara, 2010 .

Lung cancer producing interleukin-6.

S. Hayashi, S. Yokota, M. Mori, 1996, Internal medicine.

An outbreak of histoplasmosis among healthy young Japanese women after traveling to Southeast Asia.

T. Tsuji, S. Yamagoe, N. Nagata, 2010, Internal medicine.

Augmentative effect of Nocardia rubra cell-wall skeleton (N-CWS) on lymphokine-activated killer (LAK) cell induction

I. Kawase, T. Shirasaka, S. Yokota, 2004, Cancer Immunology, Immunotherapy.

An Autopsy Case of Multiple Brain Metastases of Lung Cancer with a Brain Abscess and Bacterial Meningitis

S. Yokota, M. Mori, T. Uenami, 2011 .

Macrophage tumoricidal activity as a possible antitumor mechanism associated with the local injection of allogeneic spleen cells into rats.

I. Kawase, S. Yokota, K. Komuta, 1986, Cancer research.

Effector mechanism in concomitant immunity potentiated by intratumoral injection of Nocardia rubra cell wall skeleton.

I. Kawase, S. Yokota, H. Hara, 1985, Cancer research.

Synergistic antitumor effects of BCG and monoclonal antibodies capable of inducing antibody-dependent cell-mediated cytotoxicity.

I. Kawase, T. Shirasaka, S. Yokota, 1987, Japanese journal of cancer research : Gann.

Phase III trial of docetaxel plus gemcitabine versus docetaxel in second-line treatment for non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG0104).

N. Saijo, Y. Nishiwaki, M. Ando, 2009, Annals of Oncology.

Establishment and characterization of the tumors of chronic lymphocytic leukemia cell line in nude and SCID mice.

H. Weier, M. Barcos, S. Yokota, 1993, Leukemia research.

Survivin expression in lung cancer: Association with smoking, histological types and pathological stages.

S. Sakoda, H. Maeda, S. Yokota, 2015, Oncology letters.

Establishment of new SCID and nude mouse models of human B leukemia/lymphoma and effective therapy of the tumors with immunotoxin and monoclonal antibody: marked difference between the SCID and nude mouse models in the antitumor efficacy of monoclonal antibody.

M. Barcos, S. Yokota, B. Seon, 1994, Cancer research.

Prospective Study on the Incidence of Bone Metastasis (BM) and Skeletal-Related Events (SREs) in Patients (pts) with Stage IIIB and IV Lung Cancer—CSP-HOR 13

K. Eguchi, Y. Ohashi, K. Takayama, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non-small-cell lung cancer: West Japan Thoracic Oncology Group WJTOG0105.

Masaaki Kawahara, Masahiro Fukuoka, Yasumasa Nishimura, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lymphatic invasion of micropapillary cancer cells is associated with a poor prognosis of pathological stage IA lung adenocarcinomas

H. Maeda, S. Yokota, M. Mori, 2014, Oncology letters.

Effectiveness of Tyrosine Kinase Inhibitors in Japanese Patients with Non-small Cell Lung Cancer Harboring Minor Epidermal Growth Factor Receptor Mutations: Results from a Multicenter Retrospective Study (HANSHIN Oncology Group 0212).

Satoshi Morita, Junji Uchida, Masahide Mori, 2015, Anticancer research.

A Randomized, Double-Blind, Phase IIa Dose-Finding Study of Vandetanib (ZD6474) in Japanese Patients With Non-Small Cell Lung Cancer

M. Tsuboi, K. Eguchi, N. Saijo, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Review: Pulmonary Carcinoma Associating with EML4-ALK

S. Yokota, M. Mori, H. Hirano, 2014 .

Treatment of Non-Small-Cell Lung Cancer with Erlotinib following Gefitinib-Induced Hepatotoxicity: Review of 8 Clinical Cases

S. Yokota, Y. Namba, M. Mori, 2012, Lung Cancer International.

[Case of lung cancer with chylothorax].

S. Yokota, Y. Namba, M. Mori, 2006, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society.

Monitoring EGFR T790M with plasma DNA from lung cancer patients in a prospective observational study

M. Satouchi, S. Kimura, S. Morita, 2016, Cancer science.

Cell surface tetraspanin CD9 mediates chemoresistance in small cell lung cancer.

I. Kawase, S. Goya, T. Kijima, 2010, Cancer research.

Vitiligo in a patient with lung adenocarcinoma treated with nivolumab: A case report.

S. Yokota, M. Mori, Y. Yano, 2017, Lung cancer.

[A case of Marie-Bamberger's syndrome associated with small cell carcinoma of the lung].

I. Kawase, S. Yokota, H. Hara, 1985, Nihon Kyobu Shikkan Gakkai zasshi.

Efficacy of anti-PD-1/PD-L1 antibodies after discontinuation due to adverse events in non-small cell lung cancer patients (HANSHIN 0316)

S. Negoro, N. Katakami, S. Yokota, 2018, BMC Cancer.

Inflammatory pseudotumor of the lung with rapid growth.

H. Maeda, S. Yokota, Teppei Sugano, 2009, Internal medicine.

Cancer esearch apeutics , Targets , and Chemical Biology l Surface Tetraspanin CD 9 Mediates Chemoresistance in R all Cell Lung Cancer

I. Kawase, S. Goya, T. Kijima, 2010 .

CAN-10-0996 Cancer esearch apeutics , Targets , and Chemical Biology l Surface Tetraspanin CD 9 Mediates Chemoresistance in R all Cell Lung Cancer

I. Kawase, S. Goya, T. Kijima, 2010 .

Biodistribution and in vivo antitumor efficacy of the systemically administered anti-human T-leukemia immunotoxins and potentiation of their efficacy by alpha-interferon.

S. Yokota, B. Seon, M. Yoshida, 1993, Leukemia research.

Laryngeal tuberculosis: a diagnosis that should be remembered.

S. Yokota, M. Mori, Y. Yano, 2012, Internal medicine.

Anemia in Diabetic Patients Reflects Severe Tubulointerstitial Injury and Aids in Clinically Predicting a Diagnosis of Diabetic Nephropathy

Koji Takahashi, K. Masutani, K. Miyake, 2020, Internal medicine.

Immunoregulatory T-lymphocyte functions in patients with small cell lung cancer.

S. Yokota, K. Komuta, T. Ogura, 1986, Cancer research.

Immunohisthochemical Analysis of P-Stage I Large Cell Neuroendocrine Carcinoma of the Lung: Analysis of Adhesion Molecules and Proliferative Activity

H. Maeda, S. Yokota, M. Mori, 2014 .

Pemetrexed monotherapy for chemo-naïve elderly (aged ≥80) patients with non-squamous non-small cell lung cancer: results from combined analysis of two single arm phase II studies (HANSHIN002 and 003)

M. Satouchi, T. Nishimura, S. Morita, 2017, Cancer Chemotherapy and Pharmacology.

Prospective analysis of the association between skeletal-related events and quality of life in patients with advanced lung cancer (CSP-HOR13).

K. Eguchi, Y. Ohashi, K. Takayama, 2018, Oncology letters.

Association between pulse pressure and progression of chronic kidney disease

Koji Takahashi, Kazuhiro Tada, H. Arima, 2021, Scientific Reports.

A case of pulmonary tuberculosis accompanied with immune thrombocytopenic purpura

S. Yokota, Teppei Sugano, Y. Namba, 2010 .

[A case of sarcomatoid carcinoma of the lung successfully treated with carboplatin, paclitaxel and bevacizumab].

S. Yokota, Teppei Sugano, Y. Namba, 2011, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society.

Results of a phase I/II trial of amrubicin (AMR) in combination with cisplatin (CDDP) as a first-line treatment in patients with advanced non-small cell lung cancer (NSCLC).

Y. Ichinose, M. Fukuoka, N. Masuda, 2010 .

Increased Level of Soluble E-Selectin in the Serum from Patients with Idiopathic Pulmonary Fibrosis

Y. Inoue, S. Goya, H. Kida, 2004, Inflammation.

Focal segmental glomerulosclerosis and concurrent glomerular microangiopathy after long-term imatinib administration

Koji Takahashi, K. Masutani, K. Miyake, 2021, CEN Case Reports.

I. Kawase, Y. Fujio, J. Azuma, 2012, European Journal of Clinical Pharmacology.

1271PRANDOMIZED PHASE III STUDY COMPARING GEFITINIB (G) WITH ERLOTINIB (E) IN PATIENTS (PTS) WITH PREVIOUSLY TREATED ADVANCED LUNG ADENOCARCINOMA (LA): WJOG 5108L.

M. Okada, M. Fujita, T. Nishimura, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Pleomorphic and Desmoplastic Malignant Mesotheliomas and a Malignant Mesothelioma with Osseous and Cartilaginous Differentiation: Case Reports

S. Yokota, M. Mori, H. Hirano, 2014 .

[Pleural malignant mesothelioma with osseous cartilaginous and rhabdomyogenic differentiation].

S. Yokota, T. Ogura, H. Kimura, 1998, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society.

Radiation Pneumonitis with Eosinophilic Alveolitis in a Lung Cancer Patient

S. Yokota, M. Mori, Nobuhiko Sawa, 2017, Internal medicine.

Clinical Examination of Acute Exacerbation of Idiopathic Interstitial Pneumonia (IIP) Combined With Lung Cancer After Anti-cancer Treatment

M. Hanibuchi, S. Yokota, Masami Ito, 2011 .

Comparison of Body Mass Index and Waist Circumference in the Prediction of Diabetes: A Retrospective Longitudinal Study

Koji Takahashi, Kazuhiro Tada, H. Arima, 2021, Diabetes Therapy.

[Effectiveness of isoniazid inhalation in patients with endobronchial tuberculosis].

K. Miki, S. Yokota, R. Maekura, 1999, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society.

Treatment of Non-Small-Cell Lung Cancer with Erlotinib following Gefitinib-Induced Hepatotoxicity: Review of 8 Clinical Cases

S. Yokota, Y. Namba, M. Mori, 2012, Lung cancer international.